article thumbnail

Addus HomeCare to Accelerate Acquisition Activity

Hospice News

Though the acquisition market has slowed down this year for home-based care companies, Addus HomeCare Corp. The most prominent home-based care transactions so far this year have involved payers seeking to acquire large providers with multiple business lines. NASDAQ: ADUS) remains on the hunt.

Homecare 263
article thumbnail

How Home Health, Personal Care Reimbursement Guiding Addus’ M&A Strategy

Hospice News

As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority.

professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Addus Sees Hospice Improvements, Plans to Rebalance Home Health-Personal Care M&A Activity

Hospice News

Addus HomeCare Corporation’s (NASDAQ: ADUS) hospice segment is seeing slow but steady improvement as pandemic headwinds ease. Meanwhile, the company’s near-term acquisition sights are set more on home health than in personal care amid potential payment shifts. In Q1 2023, Addus’ hospice segment brought in $49.08

article thumbnail

The Most Significant Hospice Deals So Far in 2023

Hospice News

Thus far in 2023, hospice merger and acquisition activity has deviated from prior years. But in 2023, private equity activity slowed from its formerly frenzied pace. The majority of the 13 publicly announced hospice and home health deals in 2023 have involved “bolt-ons,” or smaller entities, Kulik stated. s (NYSE: HUM) $2.8

2023 278
article thumbnail

Hospice Investors to Watch in 2024

Hospice News

Though the number of hospice M&A deals plummeted in 2023 compared to prior years, deals are still being made, and the industry may see a rebound in 2024. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. This followed its $5.4 NYSE: HUM) for $2.8

2024 278
article thumbnail

How the 2023 Home Health Rule Could Change the Game in Hospice M&A

Hospice News

Uncertainty earlier this year around Medicare’s proposed 2023 home health payment rates led some stakeholders to expect a swerve towards hospice. aggregate cut in the home health base rate, reported Hospice News sister publication Home Health Care News. Centers for Medicare & Medicaid Services (CMS) in August proposed a 4.2%

2023 189
article thumbnail

Addus Projects ‘Strong, Steady’ Hospice Growth Amid Lingering Pandemic Census Headwinds

Hospice News

Addus HomeCare Corp. NASDAQ: ADUS) saw hospice growth in 2023, despite lingering pandemic-related challenges around daily census. The company anticipates growth in its personal care business in 2024, which will have a reverberating impact in its hospice and home health service lines. billion in 2023, swelling from $951.1

2024 147